associated with SCFAs; upregulated the levels of intestinal acetic, propionic, and valeric acids; and inhibited the expression of serum TNF-α and IL-17 while downregulating the factors related to osteoclast differentiation in bone tissue to alleviate osteoporosis symptoms. Here, IL17A is linked to osteoporosis.